
Acabrunat Acalabrutinib 100 mg Capsules are an oral targeted therapy used for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
| Generic Name | Acalabrutinib |
| Manufacturer | Natco |
| Packing | 30 Capsules |
| Prescribed For | Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Capsules | $230 | £171 | A$322 | NZ$399 | ₱14,427 | ₩314,603 | lei 1,056 | HK$1,804 | RM928 | ฿7,648 | د.إ845 |
Acalabrutinib prices may vary between countries depending on the brand, dosage form, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement or medicine information.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.